⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7548673 | 0.98 | CA12 (0.47) | — | |
| SCHEMBL7548526 | 0.98 | CA12 (0.47) | — | |
| SCHEMBL8260233 | 0.98 | CA12 (0.47) | — | |
| SCHEMBL7551125 | 0.98 | CA12 (0.47) | — | |
| SCHEMBL8259026 | 0.98 | CA12 (0.47) | — | |
| SCHEMBL7549199 | 0.98 | CA12 (0.47) | — | |
| SCHEMBL7541404 | 0.98 | CA12 (0.47) | — | |
| SCHEMBL7527051 | 0.98 | CA12 (0.47) | — | |
| Hydrochloric Acid SCHEMBL7532450 | 0.95 | CA12 (0.46) | — | |
| Nitric Acid SCHEMBL2564368 | 0.93 | CA12 (0.42) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2887927-B1 | EXTENDED RELEASE COMPOSITIONS OF AN AMINO-C2-C6-ALKYL NITRATE | CARDIOLYNX AG (CH) | 2018-03-28 | — | — | EP | claimed |
| US-20180036259-A1 | NO DONORS FOR THE TREATMENT OF IMPAIRED TISSUE PERFUSION | MIRANDAPHARMACEUTICALS AG (CH) | 2018-02-08 | — | — | US | claimed |
| US-20180008558-A1 | EXTENDED RELEASE COMPOSITIONS OF AN AMINOALKYL NITRATE | CARDIOLYNX AG (CH) | 2018-01-11 | — | — | US | claimed |
| US-20170100350-A1 | EXTENDED RELEASE COMPOSITIONS OF AN AMINOALKYL NITRATE | CARDIOLYNX AG (CH) | 2017-04-13 | — | — | US | claimed |
| WO-2016135262-A1 | NO DONORS FOR THE TREATMENT OF IMPAIRED TISSUE PERFUSION | CARDIOLYNX AG (CH) | 2016-09-01 | — | — | WO | claimed |
| WO-2016135263-A1 | NO DONORS FOR THE TREATMENT OF STRESS-INDUCED PULMONARY HAEMORRHAGE IN ANIMALS | SCHERHAG ARMIN (CH) | 2016-09-01 | — | — | WO | claimed |
| CN-104869985-A | Extended release compositions of an aminoalkyl nitrate | CARDIOLYNX AG | 2015-08-26 | — | — | CN | claimed |
| US-20150216992-A1 | EXTENDED RELEASE COMPOSITIONS OF AN AMINOALKYL NITRATE | CARDIOLYNX AG (CH) | 2015-08-06 | — | — | US | claimed |
| EP-2887927-A1 | EXTENDED RELEASE COMPOSITIONS OF AN AMINOALKYL NITRATE | Cardiolynx AG (CH) | 2015-07-01 | — | — | EP | claimed |
| WO-2014029841-A1 | EXTENDED RELEASE COMPOSITIONS OF AN AMINOALKYL NITRATE | CARDIOLYNX AG (CH) | 2014-02-27 | — | — | WO | claimed |
| EP-2887927-B1 | EXTENDED RELEASE COMPOSITIONS OF AN AMINO-C2-C6-ALKYL NITRATE | CARDIOLYNX AG (CH) | 2018-03-28 | — | — | EP | disclosed |
| US-20180036259-A1 | NO DONORS FOR THE TREATMENT OF IMPAIRED TISSUE PERFUSION | MIRANDAPHARMACEUTICALS AG (CH) | 2018-02-08 | — | — | US | disclosed |
| US-20180008558-A1 | EXTENDED RELEASE COMPOSITIONS OF AN AMINOALKYL NITRATE | CARDIOLYNX AG (CH) | 2018-01-11 | — | — | US | disclosed |
| US-9631280-B2 | Method of manufacturing palladium thin film by using electroless-plating method | SOONGSIL UNIVERSITY RESEARCH CONSORTIUM TECHNO-PARK (KR) | 2017-04-25 | — | — | US | disclosed |
| US-20170100350-A1 | EXTENDED RELEASE COMPOSITIONS OF AN AMINOALKYL NITRATE | CARDIOLYNX AG (CH) | 2017-04-13 | — | — | US | disclosed |
| US-20150056378-A1 | METHOD OF MANUFACTURING PALLADIUM THIN FILM BY USING ELECTROLESS-PLATING METHOD | SOONGSIL UNIVERSITY RESEARCH CONSORTIUM TECHNO-PARK (KR) | 2015-02-26 | — | — | US | disclosed |
| WO-2014029841-A1 | EXTENDED RELEASE COMPOSITIONS OF AN AMINOALKYL NITRATE | CARDIOLYNX AG (CH) | 2014-02-27 | — | — | WO | disclosed |
| EP-2614050-A1 | 1,5-DIARYL-2-ALKYLPYRROLE-3-SUBSTITUTED NITRO ESTERS, SELECTIVE COX-2 INHIBITORS AND NITRIC OXIDE DONORS | Rottapharm S.p.A. (IT) | 2013-07-17 | — | — | EP | disclosed |
| US-20130165494-A1 | 1,5-Diaryl-2-alkylpyrrole-3-Substituted Nitro Esters, Selective COX-2 Inhibitors and Nitric Oxide Donors | ROTTAPHARM S.P.A. (IT) | 2013-06-27 | — | — | US | disclosed |
| WO-2012032479-A1 | L,5-DIARYL-2-ALKVLPVRROLE-3-SUBSTITUTED NITRO ESTERS, SELECTIVE COX-2 INHIBITORS AND NITRIC OXIDE DONORS | ROTTAPHARM S.P.A. (IT) | 2012-03-15 | — | — | WO | disclosed |